Administration | Clinton 2nd administration | Bush administrations | Obama administration | All | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | Total | |
Prescription Drug Promotion | 140 | 162 | 108 | 79 | 69 | 27 | 25 | 23 | 29 | 22 | 20 | 21 | 43 | 52 | 30 | 850 |
Office of Scientific Investigations | 2 | 4 | 8 | 5 | 11 | 2 | 2 | 3 | 6 | 9 | 10 | 16 | 20 | 15 | 18 | 131 |
Compliance | 1 | 1 | 2 | 12 | 19 | 10 | 2 | 1 | 40 | 17 | 105 | |||||
Manufacturing and Product Quality | 14 | 7 | 5 | 11 | 6 | 1 | 1 | 3 | 2 | 3 | 4 | 8 | 16 | 17 | 98 | |
Security, Integrity and Recalls | 7 | 8 | 1 | 1 | 4 | 1 | 20 | 3 | 6 | 6 | 2 | 59 | ||||
Compliance Risk Management and Surveillance | 1 | 1 | ||||||||||||||
Drugs and Labeling Compliance | 1 | 1 | ||||||||||||||
Prescription Drug Compliance | 1 | 1 | ||||||||||||||
Manufacturing and Product Quality/Division of Compliance Risk Management and Surveillance | 1 | 1 | ||||||||||||||
Unapproved Drugs and Labeling Compliance | 1 | 1 | ||||||||||||||
District Offices | 94 | 116 | 96 | 98 | 108 | 81 | 58 | 71 | 60 | 81 | 29 | 85 | 60 | 89 | 93 | 1,219 |
Total | 258 | 299 | 219 | 195 | 196 | 123 | 105 | 108 | 102 | 117 | 83 | 129 | 177 | 195 | 161 | 2,467 |